Andrew D. Dickinson
2020
Compensation breakdown
| Non-Equity Incentive Plan | $1,704,300 |
|---|---|
| Option Awards | $874,968 |
| Salary | $986,538 |
| Stock Awards | $2,260,949 |
| Other | $15,000 |
| Total | $5,841,755 |
Dickinson received $2.3M in stock awards, accounting for 39% of the total pay in 2020.
Dickinson also received $1.7M in non-equity incentive plan, $875K in option awards, $986.5K in salary and $15K in other compensation.
Rankings
In 2020, Andrew D. Dickinson's compensation ranked 1,817th out of 13,090 executives tracked by ExecPay. In other words, Dickinson earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,817 out of 13,090 | 86th |
Division Manufacturing | 700 out of 5,617 | 88th |
Major group Chemicals And Allied Products | 252 out of 2,248 | 89th |
Industry group Drugs | 211 out of 1,948 | 89th |
Industry Biological Products, Except Diagnostic Substances | 61 out of 411 | 85th |
Pay ratio
| Andrew D. Dickinson's Pay | $5,841,755 |
|---|---|
| Median Employee's Pay | $250,190 |
| Pay Ratio | 23to 1 |
In 2020, the annual total compensation of Andrew D. Dickinson was $5,841,755.
The annual total compensation of the median employee at Gilead Sciences was $250,190.
The ratio of Andrew D. Dickinson's pay to the pay of median employee was therefore 23 to one.
Dickinson's colleagues
We found four more compensation records of executives who worked with Andrew D. Dickinson at Gilead Sciences in 2020.